IL100853A0 - Msh peptide derivatives,their preparation and pharmaceutical compositions comprising them - Google Patents

Msh peptide derivatives,their preparation and pharmaceutical compositions comprising them

Info

Publication number
IL100853A0
IL100853A0 IL100853A IL10085392A IL100853A0 IL 100853 A0 IL100853 A0 IL 100853A0 IL 100853 A IL100853 A IL 100853A IL 10085392 A IL10085392 A IL 10085392A IL 100853 A0 IL100853 A0 IL 100853A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
peptide derivatives
msh peptide
msh
Prior art date
Application number
IL100853A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL100853A0 publication Critical patent/IL100853A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/086Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being alphaMSH, alpha melanocyte stimulating hormone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL100853A 1991-02-05 1992-02-03 Msh peptide derivatives,their preparation and pharmaceutical compositions comprising them IL100853A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102450A GB9102450D0 (en) 1991-02-05 1991-02-05 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
IL100853A0 true IL100853A0 (en) 1992-11-15

Family

ID=10689561

Family Applications (1)

Application Number Title Priority Date Filing Date
IL100853A IL100853A0 (en) 1991-02-05 1992-02-03 Msh peptide derivatives,their preparation and pharmaceutical compositions comprising them

Country Status (11)

Country Link
EP (1) EP0498771A3 (xx)
JP (1) JPH04347000A (xx)
AU (1) AU1065392A (xx)
CA (1) CA2060537A1 (xx)
FI (1) FI920456A (xx)
GB (1) GB9102450D0 (xx)
IE (1) IE920357A1 (xx)
IL (1) IL100853A0 (xx)
NZ (1) NZ241496A (xx)
TW (1) TW221296B (xx)
ZA (1) ZA92827B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
US6001364A (en) 1993-05-05 1999-12-14 Gryphon Sciences Hetero-polyoxime compounds and their preparation by parallel assembly
US6174530B1 (en) 1993-05-05 2001-01-16 Gryphon Sciences Homogeneous polyoxime compositions and their preparation by parallel assembly
ES2146649T3 (es) 1993-05-05 2000-08-16 Keith Rose Compuestos de polioximas y su preparacion.
KR100999044B1 (ko) 2008-03-26 2010-12-09 한국원자력연구원 킬레이트제 접합 α-MSH 펩타이드 유도체, 이의제조방법 및 이를 유효성분으로 함유하는 흑색종 진단 및치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3851002T2 (de) * 1987-05-22 1995-02-02 University Patents, Inc., Westport, Conn. Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung.
WO1990003798A2 (en) * 1988-10-04 1990-04-19 Cancer Research Campaign Technology Limited Targetting agents
NZ234173A (en) * 1989-06-23 1993-10-26 Cancer Res Campaign Tech Alpha-melanocyte stimulating hormone derivative (alphamsh)-targetted moiety conjugate

Also Published As

Publication number Publication date
EP0498771A3 (en) 1992-11-25
EP0498771A2 (en) 1992-08-12
ZA92827B (en) 1993-08-05
CA2060537A1 (en) 1993-12-15
FI920456A (fi) 1992-08-06
AU1065392A (en) 1992-08-13
FI920456A0 (fi) 1992-02-03
TW221296B (xx) 1994-02-21
IE920357A1 (en) 1992-08-12
JPH04347000A (ja) 1992-12-02
GB9102450D0 (en) 1991-03-20
NZ241496A (en) 1994-09-27

Similar Documents

Publication Publication Date Title
IL103612A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
IL101864A0 (en) Thiopyranopyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL103198A0 (en) Benzanilide derivatives,their preparation and pharmaceutical compositions containing them
IL103197A0 (en) Benzanilide derivatives,their preparation and pharmaceutical compositions containing them
IL103199A0 (en) Benzanilide derivatives,their preparation and pharmaceutical compositions containing them
IL99225A0 (en) 3-amidopyrazole derivatives,their preparation and pharmaceutical compositions containing them
IL100262A0 (en) Alpha-oxoacetamide derivatives,their preparation and pharmaceutical compositions containing them
IL101380A0 (en) Bis-naphthalimides,their preparation and pharmaceutical compositions containing them
IL108218A0 (en) Benzanilide derivatives, their preparation and pharmaceutical compositions containing them
NZ243206A (en) Thiazole derivatives, preparation and pharmaceutical compositions thereof
IL97050A0 (en) 4-isoxazolecarboxamide derivatives,pharmaceutical compositions containing them and their preparation
IL98542A0 (en) Benzoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL109073A0 (en) Amidine derivatives, their preparation and pharmaceutical compositions containing them
IL97475A0 (en) Glycinamide derivatives,their preparation,pharmaceutical compositions containing them,and their application
IL103502A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL102500A0 (en) 3-deoxy-mannosamine derivatives,their preparation and pharmaceutical compositions containing them
GB9112509D0 (en) Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
IL104042A0 (en) Substituted diphenylsulfides,their preparation and pharmaceutical compositions containing them
IL99637A0 (en) 5h-benzodiazepine derivative,its preparation and pharmaceutical compositions containing it
IL105774A0 (en) Thienothiazine derivatives,their preparation and pharmaceutical compositions containing them
IL105370A0 (en) Propenoyl-imidazole derivatives,their preparation and pharmaceutical compositions containing them
HUT70031A (en) Alfa, omega-diarylalkane derivatives, their preparation and pharmaceutical compositions containing them
IL100853A0 (en) Msh peptide derivatives,their preparation and pharmaceutical compositions comprising them
IL107175A0 (en) Benzimidazoles, their preparation and pharmaceutical compositions comprising them
IL96216A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them